Advances in Shared Decision Making and Treatment in AML at VU University Medical Center

Advances in Shared Decision Making and Treatment in AML at VU University Medical Center
paly

Learn about the latest research and treatment options for acute myeloid leukemia (AML), including the use of autologous and allogeneic stem cell transplantation and the introduction of donor immune cells to restore bone marrow function. Discover the benefits of shared decision making in the doctor's office, with presentations by experts from VU University Medical Center in Amsterdam.

  • Uploaded on | 1 Views
  • theresia theresia

About Advances in Shared Decision Making and Treatment in AML at VU University Medical Center

PowerPoint presentation about 'Advances in Shared Decision Making and Treatment in AML at VU University Medical Center'. This presentation describes the topic on Learn about the latest research and treatment options for acute myeloid leukemia (AML), including the use of autologous and allogeneic stem cell transplantation and the introduction of donor immune cells to restore bone marrow function. Discover the benefits of shared decision making in the doctor's office, with presentations by experts from VU University Medical Center in Amsterdam.. The key topics included in this slideshow are shared decision making, acute myeloid leukemia, stem cell transplantation, bone marrow function, VU University Medical Center,. Download this presentation absolutely free.

Presentation Transcript


1. VU University Medical Center Amsterdam The Netherlands

2. VU University Medical Center Amsterdam The Netherlands Shared decision making in de spreekkamer P.C.Huijgens 21 september 2013

3. VU University Medical Center Amsterdam The Netherlands Survival in acute myeloid leukemia

4. VU University Medical Center Amsterdam The Netherlands Stamceltransplantatie autoloog versus allogeen redden van beenmergfunctie introductie van afweer- cellen van donor

5. VU University Medical Center Amsterdam The Netherlands AMJ Braamse et al Bone Marrow Transplantation 2011

6. VU University Medical Center Amsterdam The Netherlands 6 Profilen van ziekte maar ook van zieke en diens omgeving

7. VU University Medical Center Amsterdam The Netherlands 35 artikelen werden gencludeerd : - 19 320 patinten - follow-up metingen varirend van een paar dagen tot 3 jaar na transplantatie AMJ Braamse et al Bone Marrow Transplantation 2011 Welke factoren voorspellen kwaliteit van leven na autologe of allogene stamceltransplantatie ?

8. VU University Medical Center Amsterdam The Netherlands Conclusie AMJ Braamse et al Bone Marrow Transplantation 2011 Verhoogd risico op een lagere kwaliteit van leven bestaat bij : - Patinten met distress vr de transplantatie - Patinten met weinig sociale steun - Jongere patinten - Vrouwelijke patinten

9. VU University Medical Center Amsterdam The Netherlands HUMAN DEVELOPMENT INDEX (HDI) Norway 0.9592 Greece 0.9106 Netherlands 0.9476 Ireland 0.9454 UK 0.9382 Germany 0.9286 Israel 0.9174 Poland 0.8562 Russia 0.7936 Romania 0.7922 Turkey 0.7534 Blood 2010;116;122-128

10. VU University Medical Center Amsterdam The Netherlands Posttraumatic growth bij kanker patienten Partners, kinderen Patient guided support Sem Onc Nurs 2008 Sem Onc Nurs 2008 Onderzoeksagenda?

11. VU University Medical Center Amsterdam The Netherlands Onderzoeksagenda? Sociale condities? Sociaal netwerk?

12. VU University Medical Center Amsterdam The Netherlands Hoe de patient te individualiseren?

13. VU University Medical Center Amsterdam The Netherlands

14. VU University Medical Center Amsterdam The Netherlands Situatie in regioziekenhuis Specialist Maatschap Ziekenhuis Ziektekostenverzekeringen

15. VU University Medical Center Amsterdam The Netherlands Situatie in UMC Specialist Ziektekosten- Afdelingshoofd verzekeringen Ziekenhuis

16. VU University Medical Center Amsterdam The Netherlands Verschillen in verantwoordelijkheden Personeel Faciliteiten Apotheekbudget Verwijzingspatroon

17. VU University Medical Center Amsterdam The Netherlands Verschillen in verantwoordelijkheden Minuten voor controle patient Minuten voor nieuwe patient Budget voor trialparticipatie

18. VU University Medical Center Amsterdam The Netherlands

19. VU University Medical Center Amsterdam The Netherlands Hoe de dokter te individualiseren?

20. 2008 76 NL sites 2011 A B C-SCT / C-HIC C-HIC C-SCT C (totaal) D 8 5 - - - 11 44 8 4 3+3 5 3+1 11+4 25+23 5 up-grades / 3 down-grades / 1 no echelon

21. Consultation area of VUmc Hematology Consultation hospitals: BovenIJ Amsterdam SLAZ Amsterdam Gemini Den Helder MCA Alkmaar RKZ Beverwijk WFG Hoorn ZMC Zaandam KG Haarlem Spaarne Hoofddorp Amstelland Amstelveen Gelre Apeldoorn Gelre Zutphen IJsselmeer ZH, Lelystad Cooperation for transplantation Allogeneic : Isala klinieken, Zwolle Autologous : SLAZ, Amsterdam; Spaarne, Hoofddorp; WFG, Hoorn Amstelveen Zutphen Hoofddorp

22. Zorg en onderzoek kwaliteitsmonitoring NFK studies farma behandel- adviezen iMTA IKNL zorg publicaties net data

23. VU University Medical Center Amsterdam The Netherlands Shared decision making Profilen van ziekte, zieke en diens omgeving Profilen van behandelteam Individualiseren van patient / dokter verhouding a